Moderna vaccine shows 94% prevention in overseas trial

KDCA announces analysis results from Canadian study of people who received 1st dose of the vaccine… announced 290 thousand Moderna doses introduced on the 22nd

Moderna’s COVID-19 vaccine was found to be 94.1% effective in preventing COVID-19.

 

The results were analyzed and presented by the disease prevention and control authorities based on the results of the observation made on 420,000 people who receive their first vaccination in Canada.

 

In Korea, 290,000 doses of the Moderna vaccine were introduced on the 22nd.

 

The COVID-19 Vaccination Response Team (Head: Eun Kyeong Jeong) explained the vaccine’s prevention effect as workers in hospital-level medical institutions were administered the Moderna vaccine from June to July, and people in their 50s will be receiving the Moderna vaccine from the 26th.

 

◆Effect of vaccination = Results from a Phase III clinical trial on 30,420 people showed that the Moderna vaccine was 94.1% effective.

 

In its effect against preventing variants that were conducted on 421,073 people in Canada who received their first dose of the Moderna vaccine, the vaccine had an 83% effect on the Alpha variant, 77% effect on the Beta/Gamma variant, and 72% effect on the Delta variant.

 

In addition, the vaccine’s effectiveness in preventing hospitalization and deaths after the first dose, the vaccine had a 79% effect on the Alpha variant, 89% effect on the Beta/Gamma variant, and 96% effect on the Delta variant

로나19 모더나 백신 변이주에 대한 백신효능.

The authorities also provided guidelines on how to respond to adverse reactions for a safe vaccination with the Moderna vaccine.

 

People who are vaccinated should stay at the institution for 15 to 30 minutes after vaccine administration to be observed for adverse reactions and should be closely monitored for over 3 hours even after returning home.

 

The vaccinated person should be observed with special attention for at least 3 days after vaccination, and people with a high fever or abnormal physical symptoms must immediately seek medical attention.

 

In particular, the Vaccination Response Team added that people who are suspected of symptoms of myocarditis or pericarditis after vaccination, and people with facial fillers who show facial swelling should seek immediate medical attention, and requested the institutions to report the adverse reactions.

 

◆Vaccine introduction status and plan = On the 22nd, the KDCA announced that a total of 24.92 million doses of COVID-19 vaccines, including the 290,000 doses of the Moderna vaccine that were introduced to Korea.

 

In addition, approximately 31 million doses will be additionally introduced until late August, and the detailed schedule for each vaccine will be provided to the extent allowed as soon as the discussions are finalized with the relevant pharmaceutical companies.

 

Meanwhile, the COVID-19 Vaccination Response Team said 77.2% (5,847,769) of the subjects eligible for vaccination completed their reservations as of midnight on the 22nd.

 

83.2 % of the subjects aged 55 to 59, and 72.3% of the subjects aged 50 to 54 completed their vaccine reservations.